Risk factors and birth prevalence of birth defects and inborn errors of metabolism in Al Ahsa, Saudi Arabia

Insights

Consanguinity is a significant risk factor for birth defects and inborn errors of metabolism in Saudi Arabia. This study highlights the need for genetic counseling and interventions to mitigate these risks.

Area of Science:

  • Medical Genetics
  • Pediatrics
  • Public Health

Background:

  • Birth defects and inborn errors of metabolism contribute to adverse perinatal and neonatal outcomes.
  • Understanding their prevalence is crucial for targeted interventions.

Purpose of the Study:

  • To investigate the pattern and prevalence of birth defects and metabolic errors in Al-Ahsa Governorate, Saudi Arabia.
  • To identify associated risk factors.

Main Methods:

  • Retrospective case-control study (April 2006-2009).
  • Included neonates with birth defects or metabolic errors; controls were healthy live births.
  • Utilized ICD-10 codes and blood tests for genetic disorders.

Main Results:

  • Prevalence: 1.14% for birth defects, 0.17% for metabolic errors.
  • Common birth defects: craniofacial malformations. Most common metabolic error: 3-methylcrotonyl-CoA carboxylase deficiency.
  • Risk factors: Consanguinity, rural residence, and prematurity increased birth defect risk; consanguinity and low birth weight increased metabolic error risk.

Conclusions:

  • First-cousin consanguinity is the most significant risk factor for both conditions.
  • High inbreeding and consanguinity may worsen underlying recessive genetic risks.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Probability Laws01:49

Probability Laws

Overview